Clostridium difficile toxins A and B and bacterial antigens — Drug Target
All drugs that target Clostridium difficile toxins A and B and bacterial antigens — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (1)
- Clostridium difficile vaccine · Sanofi · Bacterial vaccine · Infectious Disease / Immunology
This vaccine stimulates the immune system to produce antibodies and cellular immunity against Clostridium difficile toxins and bacterial antigens to prevent infection and disease.